Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.82K Buy
310
+2
+0.6% +$44 ﹤0.01% 290
2026
Q1
$5.92K Sell
308
-163
-35% -$3.17K ﹤0.01% 297
2025
Q4
$10.1K Buy
471
+1
+0.2% +$25 ﹤0.01% 254
2025
Q3
$10.7K Sell
470
-164
-26% -$4.37K ﹤0.01% 246
2025
Q2
$16.2K Buy
634
+499
+370% +$12.7K ﹤0.01% 205
2025
Q1
$3.24K Buy
135
+2
+2% +$63 ﹤0.01% 322
2024
Q4
$4.42K Buy
133
+1
+0.8% +$36 ﹤0.01% 302
2024
Q3
$4.91K Buy
132
+1
+0.8% +$35 ﹤0.01% 274
2024
Q2
$4.57K Buy
131
+1
+0.8% +$32 ﹤0.01% 274
2024
Q1
$4.04K Buy
+130
New +$3.83K ﹤0.01% 288

Other funds holding HPQ

Kozak & Associates's HPQ Position: Q2 2026 in Review

Kozak & Associates increased its HP (HPQ) stake by 0.65% in Q2 2026, buying an estimated $44 and bringing the position to 310 shares worth $6.82K. The position accounts for ﹤0.01% of the portfolio, ranked #290.

Kozak & Associates first reported a position in HPQ in Q1 2024 and has held it in 10 quarters since. The position peaked at $16.2K in Q2 2025. 1,079 funds tracked by Wall St. Rank hold HPQ as of Q2 2026.

  • Kozak & Associates held 310 shares of HP worth $6.82K as of Q2 2026.
  • Kozak & Associates bought 2 HP shares in Q2 2026, an estimated $44.
  • HP made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #290 holding.
  • Kozak & Associates first reported a position in HP in Q1 2024 and has held it in 10 quarters since.
  • Kozak & Associates's HP position peaked at $16.2K in Q2 2025.
  • 1,079 funds tracked by Wall St. Rank held HP as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.